Boryung Pharm successfully hold Dukarb’s 1st anniversary symposium
Boryung Pharm(CEO Tae-Hong Choi) held a special symposium at Paradise City Hotel & Resort Incheon between the 9th and 10th to celebrate the Dukarb’s 1st release anniversary. Dukarb is a Kanarb/amlodipine combination medicine for the treatment of hypertension.
At the symposium participated by abo...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.